Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Severe persistent visual field constriction associated with vigabatrin. Manufacturers have started several studies.

× No keyword cloud information.

7 in total

1. Retinal function in rabbits does not improve 4-5 months after terminating treatment with vigabatrin.

Authors: Ulrika Kjellström; Sten Kjellström; Anitha Bruun; Sten Andréasson; Vesna Ponjavic
Journal: Doc Ophthalmol Date: 2006-01 Impact factor: 2.379

2. Multifocal ERG and full-field ERG in patients on long-term vigabatrin medication.

Authors: V Ponjavic; S Andréasson
Journal: Doc Ophthalmol Date: 2001-01 Impact factor: 2.379

3. Visual field constriction and electrophysiological changes associated with vigabatrin.

Authors: Dorothea Besch; Anne Kurtenbach; Eckart Apfelstedt-Sylla; Bettina Sadowski; Dieter Dennig; Christiane Asenbauer; Eberhart Zrenner; Ulrich Schiefer
Journal: Doc Ophthalmol Date: 2002-03 Impact factor: 2.379

4. Alterations in electroretinograms and retinal morphology in rabbits treated with vigabatrin.

Authors: Vesna Ponjavic; Lotta Gränse; Sten Kjellström; Sten Andréasson; Anitha Bruun
Journal: Doc Ophthalmol Date: 2004-03 Impact factor: 2.379

5. Dose-related changes in retinal function and PKC-alpha expression in rabbits on vigabatrin medication. Effect of vigabatrin in the rabbit eye.

Authors: Ulrika Kjellström; Anitha Bruun; Fredrik Ghosh; Sten Andréasson; Vesna Ponjavic
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2009-05-03 Impact factor: 3.117

6. Full-field ERG and visual fields in patients 5 years after discontinuing vigabatrin therapy.

Authors: Ulrika Kjellström; Monica Lövestam-Adrian; Sten Andréasson; Vesna Ponjavic
Journal: Doc Ophthalmol Date: 2008-01-10 Impact factor: 2.379

Review 7. Visual field defects with vigabatrin: epidemiology and therapeutic implications.

Authors: R Kälviäinen; I Nousiainen
Journal: CNS Drugs Date: 2001 Impact factor: 6.497

7 in total